Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia

Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia

Acute myeloid leukemia patients with induction failure or relapsed refractory disease have minimal chance of achieving remission with subsequent treatments. Several trials have shown the feasibility of clofarabine-based conditioning in allogeneic stem cell transplants (allo-HSCT) for non-remission A...

Full description

Bibliographic Details
Main Authors: Seema Naik, Kevin Rakszawski, Hong Zheng, David Claxton, Kentaro Minagawa, Shin Mineishi
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:International Journal of Molecular Sciences
Subjects:
AML: acute myeloid leukemia
Allo-HSCT: allogeneic transplant
Clo: clofarabine
PTCy: post-transplant cyclophosphamide
Online Access:https://www.mdpi.com/1422-0067/25/2/957

Internet

https://www.mdpi.com/1422-0067/25/2/957

Similar Items